History of Oxford Medistress
Company founded by University of Oxford following collaboration between Prof David Macdonald CBE, DSc, FRSE (University of Oxford), Oxford University’s first Professor of Wildlife Conservation, and Dr Rubina Mian (PhD Birmingham University; BSc (hons.) Liverpool University). The team is steered by Dr David Sarphie (D Phil. University of Oxford, BSc University of Notre Dame) who is a founding investor and director. The world class credentials of the team soon ignites interest from leading blue chip companies.
Early forward thinking commercial blue chip adopters include Jaguar Cars, a leading Premiership Football Team, and (latterly) AstraZeneca.
Launch of CopingCapacity Elite-Pro™ to optimise wellness in elite athletes
Launch of CopingCapacity Vet™ for use in animals, including companion animals, farmed animals and endangered species.
First revenues from product sales, with clients including the Amateur Swimming Association (UK), a leading Premiership Football Team, and AstraZeneca.
European patent granted. Inventors: Dr Rubina Mian and Prof David Macdonald
US, Japanese patents granted
Patent assigned by Isis Innovation to Oxford MediStress
Oxford MediStress makes initial entry into Formula 1 Motor Racing with a prominent F1 Team
Independent clinical study validates Oxford MediStress’ LCC™ technology as being more sensitive than cortisol for measurement of acute stress.